ACG Wealth’s GoodRx Holdings GDRX Stock Holding History

ACG Wealth’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-36	Closed	–	–	536
2022 Q2	$0	Buy	+36	New	+$401	﹤0.01%	966

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

ACG Wealth's GDRX Position: Q3 2022 in Review

ACG Wealth sold out of GoodRx Holdings (GDRX) in Q3 2022, closing a stake of 36 shares.

ACG Wealth first reported a position in GDRX in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 180 funds tracked by Wall St. Rank hold GDRX as of Q3 2022.

ACG Wealth reported no remaining GoodRx Holdings position as of Q3 2022 after selling out during the quarter.
ACG Wealth sold 36 GoodRx Holdings shares in Q3 2022.
ACG Wealth first reported a position in GoodRx Holdings in Q2 2022 and held it in 1 quarter.
ACG Wealth's GoodRx Holdings position peaked at $0 in Q2 2022.
180 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.